Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a small maintenance/template update. The change does not modify any study text, eligibility criteria, locations, or outcome data.SummaryDifference0.0%

- Check21 days agoChange DetectedA new NIH grant/contract reference (2017) was added, indicating funding information associated with the trial in the study’s identifiers.SummaryDifference0.0%

- Check28 days agoChange DetectedA new publication citation by Tonietto et al. is added to the Publications section, expanding the study's referenced literature. The citation refers to a 2026 Alzheimer's Dement publication on gantenerumab and amyloid-related imaging abnormalities.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small update to the page or site framework. No content changes are indicated in the provided changes.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the site's template or rendering.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This reflects a minor update to the page's release notes.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.